Chief Financial Officer of Travere Therapeutics, Inc. (U.S.: Nasdaq:TVTX), Clague Laura, sells 7,500 shares worth $205,500
According to Travere Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 04:05 PM, company Chief Financial Officer, Clague Laura disclosed selling 7,500 shares at a cost of $27.40. At the time of this transaction (Jan 11), this trade was worth $205,500 in total. As of Jan 11, Clague Laura now owns 31,316 shares in total worth about $819,539.7200000001.
For the last few recent trades made by Travere Therapeutics, Inc. (U.S.: Nasdaq:TVTX) Chief Financial Officer, Clague Laura, we have the following information:
- SEC Form 4 filing: Aug 17: Sold 1,407 shares at the rate of $17.12 per share. Total worth of this trade was $24,085. Total number of shares owned as of Aug 17 were 31,316
- SEC Form 4 filing: May 11: Sold 2,000 shares at the rate of $19.14 per share. Total worth of this trade was $38,280. Total number of shares owned as of May 11 were 30,223
- SEC Form 4 filing: May 12: Sold 2,000 shares at the rate of $19.46 per share. Total worth of this trade was $38,920. Total number of shares owned as of May 12 were 28,223
Posted by
George Daniels
on Thursday January 13 2022, 1:27 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
